CordovaCann Corp (LVRLF)
0.0735
+0.02
(+29.04%)
USD |
OTCM |
May 17, 16:00
CordovaCann Max Drawdown (5Y): 96.11% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 96.11% |
March 31, 2024 | 96.11% |
February 29, 2024 | 96.11% |
January 31, 2024 | 96.11% |
December 31, 2023 | 96.11% |
November 30, 2023 | 96.11% |
October 31, 2023 | 96.11% |
September 30, 2023 | 96.11% |
August 31, 2023 | 96.11% |
July 31, 2023 | 96.11% |
June 30, 2023 | 96.11% |
May 31, 2023 | 96.11% |
April 30, 2023 | 96.11% |
March 31, 2023 | 96.11% |
February 28, 2023 | 96.11% |
January 31, 2023 | 96.11% |
December 31, 2022 | 96.11% |
November 30, 2022 | 96.11% |
October 31, 2022 | 96.11% |
September 30, 2022 | 96.11% |
August 31, 2022 | 96.11% |
July 31, 2022 | 96.11% |
June 30, 2022 | 96.11% |
May 31, 2022 | 96.11% |
April 30, 2022 | 96.11% |
Date | Value |
---|---|
March 31, 2022 | 96.11% |
February 28, 2022 | 96.11% |
January 31, 2022 | 96.11% |
December 31, 2021 | 96.11% |
November 30, 2021 | 96.11% |
October 31, 2021 | 96.11% |
September 30, 2021 | 98.86% |
August 31, 2021 | 98.86% |
July 31, 2021 | 98.86% |
June 30, 2021 | 98.86% |
May 31, 2021 | 98.86% |
April 30, 2021 | 98.86% |
March 31, 2021 | 98.86% |
February 28, 2021 | 98.86% |
January 31, 2021 | 98.86% |
December 31, 2020 | 98.86% |
November 30, 2020 | 98.86% |
October 31, 2020 | 98.86% |
September 30, 2020 | 98.86% |
August 31, 2020 | 98.86% |
July 31, 2020 | 98.86% |
June 30, 2020 | 98.86% |
May 31, 2020 | 98.86% |
April 30, 2020 | 98.86% |
March 31, 2020 | 98.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.11%
Minimum
Oct 2021
98.86%
Maximum
May 2019
97.44%
Average
96.11%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -47.17 |
Beta (5Y) | 0.9411 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 101.3% |
Historical Sharpe Ratio (5Y) | -0.3621 |
Historical Sortino (5Y) | -0.8747 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.76% |